Harry M. Meade, PhD, is senior vice president of research and development at GTC Biotherapeutics, Inc.
Production of Recombinant Therapeutic Proteins in the Milk of Transgenic Animals
Capital investments in production plants represent a significant portion of the cost of new recombinant drugs